CVE-2023-38848
HIGHCVSS 7.5/10EPSS 0.69%
Last modified
CVE-2023-38848 is a high-severity vulnerability rated 7.5/10 on the CVSS scale. An issue in rmc R Beauty CLINIC Line v.13.6.1 allows a remote attacker to obtain sensitive information via crafted GET request.. EPSS estimates a 0.69% chance of exploitation in the next 30 days.
Description
An issue in rmc R Beauty CLINIC Line v.13.6.1 allows a remote attacker to obtain sensitive information via crafted GET request.
Metrics
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
Weakness Enumeration
Affected Software
| Vendor | Product | Versions |
|---|---|---|
| Linecorp | Line | 13.6.1 |
References
- https://github.com/syz913/CVE-reports/blob/main/CVE-2023-38848.mdExploit, Third Party Advisory
- https://github.com/syz913/CVE-reports/blob/main/CVE-2023-38848.mdExploit, Third Party Advisory
Timeline
- Published
- Last Modified
- Status
- Modified
Frequently Asked Questions
What is CVE-2023-38848?
An issue in rmc R Beauty CLINIC Line v.13.6.1 allows a remote attacker to obtain sensitive information via crafted GET request.
How severe is CVE-2023-38848?
CVE-2023-38848 has a CVSS score of 7.5/10 (HIGH severity). The EPSS model estimates a 0.69% probability of exploitation in the next 30 days.
How do I fix CVE-2023-38848?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.
Are you affected by CVE-2023-38848?
Run a free Strix scan to check your systems for this vulnerability.
Scan your code nowSource: NVD / NIST